Not all people with CLL demand therapy. Despite all latest innovations, the iwCLL even now suggests watchful observation for people with asymptomatic condition.86 This advice is predicated on at the least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both trials concluded that https://lordw357rsq8.sharebyblog.com/profile